Pancreatic Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Pancreatic Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-05Clinical Trial Update: Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study [Phase 2]
Phase 2 clinical trial investigating capecitabine with temozolomide and radiolabeled peptide therapy (Lutetium-177) for midgut and pancreati…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery [Phase 2]
Phase 2 clinical trial update for sapanisertib in metastatic or unresectable pancreatic neuroendocrine tumors (PENET G1/G2; refractory), wit…
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating VEGFR/PDGFR dual kinase inhibitor X-82 in combination with Everolimus for pancreatic neuroendocrine tu…
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating capecitabine, temozolomide, and bevacizumab for metastatic or unresectable pancreatic neuroendocrine tumors has com…
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg [Phase 2]
Phase 2 trial updating the efficacy and safety of lanreotide Autogel in pancreatic and midgut neuroendocrine tumors after progression on pri…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery [Phase 2]
Phase 2 clinical trial of everolimus in patients with pancreatic neuroendocrine tumors with liver metastases, previously treated with surger…
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating RAD001 (everolimus) combined with temozolomide in advanced pancreatic neuroendocrine tumors; study statu…
-
CLINICAL_TRIALS trial_result · 2020-06-17Clinical Trial Update: Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery [Phase 1, Phase 2]
Phase 1/2 trial evaluating temozolomide with pazopanib in advanced, unresectable pancreatic neuroendocrine tumors; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating Ziv-Aflibercept for pancreatic neuroendocrine tumors; study completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib [Phase 2]
A Phase 2 trial evaluating the efficacy of rechallenge with sunitinib in metastatic pancreatic neuroendocrine tumor that previously failed s…
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors [Phase 2]
Phase II study of ibrutinib in advanced carcinoid and pancreatic neuroendocrine tumors has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer [Phase 2]
Phase 2 study of temsirolimus in combination with bevacizumab in advanced endometrial, ovarian, liver, carcinoid, and pancreatic neuroendocr…
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus [Phase 2]
Phase 2 clinical trial update evaluating everolimus in patients with metastatic pancreatic neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor [NA]
This completed clinical trial assesses the efficacy and safety of radiofrequency ablation for pancreatic neuroendocrine tumors and pancreati…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: A Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET) [Phase 2]
Phase 2 trial assessing palbociclib in well/moderately differentiated metastatic pancreatic neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of AMG 479 in advanced carcinoid tumors and pancreatic neuroendocrine tumors has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers [Phase 2]
Phase 2 study of Fosbretabulin in pancreatic or gastrointestinal neuroendocrine tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Clinical trial registry update indicating completion of NCT01770405 evaluating needle-based confocal laser endomicroscopy (nCLE) for masses …
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors [NA]
Clinical trial update on doxorubicin-loaded beads for unresectable liver metastases from neuroendocrine tumors; the trial was terminated and…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor [Phase 2]
A Phase 2 clinical trial evaluating chemotherapy plus Endostatin for advanced pancreatic neuroendocrine tumors has completed, according to C…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project [Phase 1]
Phase 1 COLPAN trial evaluating near-infrared technology to assist laparoscopic resection of pancreatic lesions has completed, including pan…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer [Phase 2]
Phase 2 trial of pharmacokinetically guided everolimus in patients with breast cancer, pancreatic neuroendocrine tumors, or renal cell carci…
-
CLINICAL_TRIALS trial_result · 2016-12-20Clinical Trial Update: Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET [Phase 2]
A Phase 2 trial evaluating everolimus alone or in combination with pasireotide LAR for advanced pancreatic neuroendocrine tumors was termina…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating temsirolimus in patients with metastatic neuroendocrine tumors has completed, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors [Phase 1]
A Phase 1 trial assessing the combination of pasireotide and RAD001 (everolimus) in patients with advanced neuroendocrine tumors has complet…